Antepartum fetal surveillance in diabetic pregnant patients.
Publication/Presentation Date
11-15-1981
Abstract
The antepartum fetal surveillance (biochemical and biophysical) data of 140 pregnant diabetic patients were evaluated. We determined how often intervention occurred on the basis of abnormal tests and correlated each test with neonatal outcome. Fifteen of the total 140 patients had their pregnancies terminated because of abnormal biochemical and/or biophysical tests. An abnormal estriol (E3) value preceded the abnormal antepartum fetal heart rate testing in eight of 10 instances. We conclude that the major benefit of the antepartum fetal surveillance techniques, in this group of patients and under the present scheme, is in determining when not to intervene, thus allowing safe prolongation of pregnancy.
Volume
141
Issue
6
First Page
641
Last Page
645
ISSN
0002-9378
Published In/Presented At
Jorge CS, Artal R, Paul RH, Goebelsmann U, Gratacós J, Yeh SY, Golde SH, Mestman JH. Antepartum fetal surveillance in diabetic pregnant patients. Am J Obstet Gynecol. 1981 Nov 15;141(6):641-5. doi: 10.1016/s0002-9378(15)33304-4. PMID: 7315893.
Disciplines
Medicine and Health Sciences
PubMedID
7315893
Department(s)
Department of Obstetrics and Gynecology
Document Type
Article